Díaz, C. and Zapata, C. 2022. Profound molecular response with ponatinib in chronic phase of chronic myeloid leukemia with resistance to imatinib and dasatinib: Case report and review of the literature. Revista Médica Herediana. 33, 2 (Jul. 2022), 133–138. DOI:https://doi.org/10.20453/rmh.v33i2.4247.